PRESS: J&J Sues Glaxo Over False Advertising Claims - Reuters

Fri, 13th Mar 2015 06:31

LONDON (Alliance News) - US healthcare company Johnson & Johnson on Thursday sued UK rival GlaxoSmithKline PLC, alleging Glaxo is attempting to unlawfully win market share with false advertising at the start of the spring allergy season in the US, Reuters reports.

Two units of J&J, McNeil-PPC Inc and McNeil Consumer Healthcare, filed the suit in Manhattan, accusing Glaxo os making unsupported claims about its allergy nasal spray Flonase at the expense of McNeil's Benadryl and Zyrtec drugs.

A spokeswoman for Glaxo told Reuters the company is reviewing the lawsuit.

http://uk.reuters.com/article/2015/03/12/uk-johnson-johnson-gsk-allergy-idUKKBN0M82SI20150312

By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance

Related Shares

More News

2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a...

2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U....

1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2% *

1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal...